Aurobindo Pharma Limited — Updates, 20-03-2026: General Updates
20-03-2026 | 10:00 am
20-03-2026 | 10:00 am
Aurobindo Pharma's subsidiary, Apitoria Pharma, received a 'Voluntary Action Indicated' (VAI) classification from the US FDA for its Unit-V API facility. The inspection is now closed, indicating a positive resolution after earlier observations.
No comments yet. Be the first to comment!
